Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

Clinical trial NCT03567889 · RECRUITING

Trial details

NCT number: NCT03567889
Sponsor: Philogen S.p.A.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Melanoma Stage IIIB Melanoma Stage IIIC Melanoma Stage IIID

Start date: 2018-09-20
Primary completion: 2027-12-01
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.